INTERNATIONAL PATENT: KATHOLIEKE UNIVERSITEIT LEUVEN FILES APPLICATION FOR "GENETIC SIGNATURE FOR PREDICTING A RESPONSE TO IMMUNE CHECKPOINT INHIBITOR THERAPY"

GENEVA, May 12 -- KATHOLIEKE UNIVERSITEIT LEUVEN (K.U. Leuven Research & DevelopmentWaaistraat 6 - Box 51053000 Leuven) filed a patent application (PCT/EP2024/080633) for "GENETIC SIGNATURE FOR PREDICTING A RESPONSE TO IMMUNE CHECKPOINT INHIBITOR THERAPY" on Oct 30, 2024. With publication no. WO/2025/093579, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GARG, Abhishek (Waaistraat 6 bus 51053000 Leuven), VANMEERBEEK, Isaure (Waaistraat 6 - Box 51053000 Leuven)

Abstract: The present invention relates to a method for pr...